JRCT ID: jRCTs051180216
Registered date:27/03/2019
Sentinel node biopsy in uterine cancer
Basic Information
Recruitment status | Recruiting |
---|---|
Health condition(s) or Problem(s) studied | Uterine cancer |
Date of first enrollment | 17/08/2017 |
Target sample size | 400 |
Countries of recruitment | |
Study type | Interventional |
Intervention(s) | Sentinel navigation surgery |
Outcome(s)
Primary Outcome | Progression free survival |
---|---|
Secondary Outcome | The rate of postoperative lymph edema and lymph node recurrence |
Key inclusion & exclusion criteria
Age minimum | >= 20age old |
---|---|
Age maximum | <= 85age old |
Gender | Female |
Include criteria | Cervical cancer of stage I with tumor diameter of less than 2 cm, endometrial cancer of stage IA with endometrioid carcinoma of grade 1 or 2 |
Exclude criteria | Suspicious of lymph node metastasis on preoperative image findings Neoadjuvant chemotherapy and radiotherapy |
Related Information
Primary Sponsor | Ohmichi Masahide |
---|---|
Secondary Sponsor | |
Source(s) of Monetary Support | |
Secondary ID(s) | UMIN000028524 |
Contact
Public contact | |
Name | Tomohito Tanaka |
Address | 2-7, Daigakumachi, Takatsuki, Osaka 569-8686, Japan Osaka Japan 569-8686 |
Telephone | +81-72-683-1221 |
tomohito.tanaka@ompu.ac.jp | |
Affiliation | Osaka Medical and Pharmaceutical University Hospital |
Scientific contact | |
Name | Masahide Ohmichi |
Address | 2-7, Daigakumachi, Takatsuki, Osaka 569-8686, Japan Osaka Japan 569-8686 |
Telephone | +81-72-683-1221 |
m-ohmichi@ompu.ac.jp | |
Affiliation | Osaka Medical and Pharmaceutical University Hospital |